openPR Logo
Press release

China Nuclear Power Sector China Nuclear Power Sales Report

07-11-2017 12:24 PM CET | Energy & Environment

Press release from: Kuick Resarch

China Nuclear Power Sector China Nuclear Power Sales Report

For Report Sample Contact: or +91-11-47067990

Report Table of Contents

1. China Power Sector Overview
1.1 Installed Capacity
1.2 Electricity Generation
1.3 Current Power Demand
1.4 Future Power Demand

2. China Nuclear Power Sector Overview
2.1 China Nuclear Energy Programme
2.2 Rationale behind China Nuclear Power

3. China Nuclear Power Sector Indicators
3.1 Installed Capacity
3.2 Projected Capacity
3.3 Nuclear Fuel Procurement

4. China Nuclear Power Plants Overview
4.1 Existing Nuclear Plants
4.2 Upcoming Nuclear Power Plants

5. China Nuclear Power Sector Regulatory Landscape
5.1 National Development & Reform Commission (NDRC)
5.2 State Administration of Science, Technology and Industry for National Defense (SASTIND)
5.3 State-owned Assets Supervision & Administration Commission (SASAC)
5.4 China Atomic Energy Authority (CAEA)
5.5 National Nuclear Safety Administration (NNSA)
5.6 Ministry of Environmental Protection (MEP)
5.7 Department of Nuclear Safety Management

6. China Nuclear Power Generation Companies
6.1 China National Nuclear Corporation (CNNC)
6.2 China General Nuclear Power Group (CGN)
6.3 State Power Investment Corporation
6.4 Other Major Power Generating Companies active in Nuclear Sector

7. China Nuclear Power Sector Dynamics
7.1 Favorable Parameters
7.2 Key Challenges

8. China Nuclear Power Plant Infrastructure & Technology
8.1 Plant Infrastructure
8.1.1 Common Nuclear Reactor Types in China
8.1.2 China Nuclear Power Plants
8.2 Fuel
8.2.1 Domestic Supply
8.2.2 International Supply

9. Essence & Opportunities of Nuclear Power in China
9.1 Doing Away with Overdependence on Coal Based Power
9.2 Cater Rising Electricity Demand in Environmentally Safe & Economically

10. China as an Emerging Exporter of Nuclear Reactor Technology

11. China Nuclear Power Sector Future Outlook

12. China Nuclear Power Sector Conclusion

Download Report:

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
KuicK Research
Avanta Business Center 4th Floor,
Statesman House Barakhamba Road,
Connaught Place New Delhi – 110 001, India

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release China Nuclear Power Sector China Nuclear Power Sales Report here

News-ID: 618973 • Views: 351

More Releases from Kuick Resarch

Global Trispecific Antibodies Market Opportunity & Clinical Trials Insight 2024
"Global Trispecific Antibodies Market Opportunity & Clinical Trials Insight 2024" Report Highlights: • Commutative Market Opportunity During Initial 5 years of Commercialization: > US$ 2 Billion • Trispecific Antibodies In Clinical Trials: > 8 Antibodies • Highest Phase of Development: Phase I/II • Cancer Dominating Trispecific Antibodies Trials: > 5 Antibodies • Numab Therapeutics Dominating the Trispecific Development Pipeline • Prevention & Second Line Therapy Key Focus of Development of Trispecific Antibodies Download Report: Trispecific cancer antibody therapy market at
Global BiTE Antibodies Market, Price, Sales & Clinical Trials Insight 2025
"Global BiTE Antibodies Market, Price, Sales & Clinical Trials Insight 2025" Report Highlights: • Global BiTE Antibody Market Opportunity Insight (2021-2025) • Currently Only 1 BiTE Commercially Available In Market: Blinatumomab (Blincyto) • Blincyto Dosage & Market Sales Analysis ( Yearly, Quarterly & Regional Sales) • Global BiTE Antibody Clinical Trials Indicators by Phase, Company, Country, Indication & Patient Segment • Global Bispecific T-Cell Engagers Market Dynamics Download Report: The research report, "Global BiTE Antibodies Market , Price, Sales &
Global BCL-2 (B Cell Lymphoma 2) Inhibitors Market & Clinical Trials Insight 202 …
"Global BCL-2 (B Cell Lymphoma 2) Inhibitors Market & Clinical Trials Insight 2025" Report Highlights: • Global BCL-2 Inhibitors Market Opportunity: >US$ 4 Billion by 2025 • Insight on Market Indicators & Approved Drugs Sales Data • Global BCL-2 Inhibitors Market Absolute Growth: >300% ( 97% CAGR, 2018 - 2020) • Comprehensive Information On Ongoing Clinical Trials • Global BCL-2 inhibitors Clinical Trials By Company, Indication & Phase • Venetoclax Is The First Approved Drug Belonging To The Class Of BCL2
Global Antibody Drug Conjugate Market Sales Size Opportunity To Surpass US$ 10 B …
"Novel Cancer Antibody Drug Conjugates to Drive Cancer Therapeutics Market With More Than 290 Cancer Antibodies In Clinical Trials Pipeline Says Kuick Research" "Global Cancer Antibody Drug Conjugate Market, Price, Dosage & Clinical Trials Insight 2026" Report Highlights: • Global Cancer Antibody Drug Conjugate (ADC) Pipeline: 297 Drugs • Marketed Cancer Antibody Drug Conjugate: 9 Drugs • Antibody Drug Conjugate Marketed Opportunity: > US$ 13 Billion By 2026 • Majority of Drug Trials Are For Second Line Therapy

All 5 Releases

More Releases for Nuclear

Nuclear Reactor Market
Construction of new nuclear across the globe is one of the primary reasons behind the accelerating growth of the global nuclear reactor market, states TMR Research in a new research report. The report is titled, “Nuclear Reactor Market – Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017 – 2025.” Click on the link below to request a sample copy of the report The worldwide market for nuclear reactors is
Nuclear Steam Generator Market
Steam generator is a device which is used to create steam by boiling water. Steam generators are also referred as heat exchangers used to convert water particles into steam from heat produced in a nuclear reactor plant. Nuclear steam generator is used in high pressure water reactor having primary loop (piping system that contains coolant) and secondary loops (have separate piping system, here water is converted to steam to rotate
Nuclear Energy Industry Analysis of Nuclear Fuels Market 2017-2021
Nuclear fuel is a substance used to initiate and sustain a nuclear fission reaction in nuclear power stations to generate heat. This heat powers turbine to produce usable electrical energy. A nuclear reactor is a structure in which fissile material undergoes a controlled, self-sustaining nuclear reaction with simultaneous release of energy, which can be used to generate electricity. . . – Get Sample Report_ ' ' Global nuclear fuels market to grow
Nuclear Air Filtration Market
In this report, the Asia-Pacific Nuclear Air Filtration market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Nuclear Air Filtration for these regions, from 2012 to
UAE Nuclear Power Sector UAE Nuclear Power Sales Report
For Report Sample Contact: or +91-11-47067990 Report Table of Contents 1. UAE Power Sector Scenario 1.1 Existing Power Generation Outlook 1.2 Current & Projected Power Demand 2. Why UAE Energy Policy beyond Oil & Gas? 3. UAE Nuclear Power Sector Overview 3.1 UAE Entering into Nuclear Power Sector 3.2 Nuclear Policy Overview 4. UAE Nuclear Power Sector Dynamics 4.1 Favorable Parameters 4.2 Nuclear Power Sector
Nuclear Medicine/Radiopharmaceuticals Market
Radiopharmaceuticals are unique medicinal formulations that contain radioisotopes and are used in clinical applications for diagnosis and therapy. The facilities and procedures for production, use, and storage of radiopharmaceuticals are subject to license approval either by national or regional authorities such as Nuclear Regulatory Commission (NRC) of U.S, Atomic Energy Commission (AEC) of U.S., or Atomic Energy Regulatory Board (AERB) of India. Licensing includes compliance regarding pharmaceutical preparations and use